Persons with dispensed medicines; origin

Changed on: 20/12/2023 02:00

Persons with dispensed medicines; origin
Sex	Age	Origin	Medicine group (ATC)	Periods	Persons with medicines, relative (%)	Defined daily doses (DDD), relative (number per 1 000 persons)
Total male and female	Total age	Total	C01B Antiarrhythmics, class I and III	2022*	0.39	890
Total male and female	Total age	Origin: born in the Netherlands	C01B Antiarrhythmics, class I and III	2022*	0.43	980
Total male and female	Total age	Origin: born in NL, parents in NL	C01B Antiarrhythmics, class I and III	2022*	0.47	1,066
Total male and female	Total age	Origin: born in NL, parent(s) abroad	C01B Antiarrhythmics, class I and III	2022*	0.19	436
Total male and female	Total age	Origin: born in NL, 1 parent born in NL	C01B Antiarrhythmics, class I and III	2022*	0.31	691
Total male and female	Total age	Origin: born in NL,2 parents born abroad	C01B Antiarrhythmics, class I and III	2022*	0.06	127
Total male and female	Total age	Origin: born abroad	C01B Antiarrhythmics, class I and III	2022*	0.18	417
Total male and female	Total age	Origin country: The Netherlands	C01B Antiarrhythmics, class I and III	2022*	0.47	1,066
Total male and female	Total age	Origin country: abroad	C01B Antiarrhythmics, class I and III	2022*	0.19	425
Total male and female	Total age	Origin country: Europe (excl. NL)	C01B Antiarrhythmics, class I and III	2022*	0.26	596
Total male and female	Total age	Origin country: outside Europe	C01B Antiarrhythmics, class I and III	2022*	0.14	335
Total male and female	Total age	Origin country: Morocco	C01B Antiarrhythmics, class I and III	2022*	0.12	299
Total male and female	Total age	Origin country: Turkey	C01B Antiarrhythmics, class I and III	2022*	0.14	330
Total male and female	Total age	Origin country: Suriname	C01B Antiarrhythmics, class I and III	2022*	0.14	325
Total male and female	Total age	Origin country: Dutch Caribbean	C01B Antiarrhythmics, class I and III	2022*	0.15	358
Total male and female	Total age	Origin country: Indonesia	C01B Antiarrhythmics, class I and III	2022*	0.48	1,099
Total male and female	Total age	Origin country: Outside Europe (exc. 5..	C01B Antiarrhythmics, class I and III	2022*	0.07	156
Total male and female	0 to 14 years	Total	C01B Antiarrhythmics, class I and III	2022*	0.00	6
Total male and female	0 to 14 years	Origin: born in the Netherlands	C01B Antiarrhythmics, class I and III	2022*	0.00	6
Total male and female	0 to 14 years	Origin: born in NL, parents in NL	C01B Antiarrhythmics, class I and III	2022*	0.00	7
Total male and female	0 to 14 years	Origin: born in NL, parent(s) abroad	C01B Antiarrhythmics, class I and III	2022*	0.00	3
Total male and female	0 to 14 years	Origin: born in NL, 1 parent born in NL	C01B Antiarrhythmics, class I and III	2022*	0.00	5
Total male and female	0 to 14 years	Origin: born in NL,2 parents born abroad	C01B Antiarrhythmics, class I and III	2022*	0.00	2
Total male and female	0 to 14 years	Origin: born abroad	C01B Antiarrhythmics, class I and III	2022*	0.00	5
Total male and female	0 to 14 years	Origin country: The Netherlands	C01B Antiarrhythmics, class I and III	2022*	0.00	7
Total male and female	0 to 14 years	Origin country: abroad	C01B Antiarrhythmics, class I and III	2022*	0.00	4
Total male and female	0 to 14 years	Origin country: Europe (excl. NL)	C01B Antiarrhythmics, class I and III	2022*	0.00	5
Total male and female	0 to 14 years	Origin country: outside Europe	C01B Antiarrhythmics, class I and III	2022*	0.00	3
Total male and female	0 to 14 years	Origin country: Morocco	C01B Antiarrhythmics, class I and III	2022*	0.00	0
Total male and female	0 to 14 years	Origin country: Turkey	C01B Antiarrhythmics, class I and III	2022*	0.00	1
Total male and female	0 to 14 years	Origin country: Suriname	C01B Antiarrhythmics, class I and III	2022*	0.00	0
Total male and female	0 to 14 years	Origin country: Dutch Caribbean	C01B Antiarrhythmics, class I and III	2022*	0.01	7
Total male and female	0 to 14 years	Origin country: Indonesia	C01B Antiarrhythmics, class I and III	2022*	0.00	0
Total male and female	0 to 14 years	Origin country: Outside Europe (exc. 5..	C01B Antiarrhythmics, class I and III	2022*	0.00	5
Total male and female	15 to 24 years	Total	C01B Antiarrhythmics, class I and III	2022*	0.01	20
Total male and female	15 to 24 years	Origin: born in the Netherlands	C01B Antiarrhythmics, class I and III	2022*	0.01	22
Total male and female	15 to 24 years	Origin: born in NL, parents in NL	C01B Antiarrhythmics, class I and III	2022*	0.01	24
Total male and female	15 to 24 years	Origin: born in NL, parent(s) abroad	C01B Antiarrhythmics, class I and III	2022*	0.01	18
Total male and female	15 to 24 years	Origin: born in NL, 1 parent born in NL	C01B Antiarrhythmics, class I and III	2022*	0.01	7
Total male and female	15 to 24 years	Origin: born in NL,2 parents born abroad	C01B Antiarrhythmics, class I and III	2022*	0.01	27
Total male and female	15 to 24 years	Origin: born abroad	C01B Antiarrhythmics, class I and III	2022*	0.00	10
Total male and female	15 to 24 years	Origin country: The Netherlands	C01B Antiarrhythmics, class I and III	2022*	0.01	24
Total male and female	15 to 24 years	Origin country: abroad	C01B Antiarrhythmics, class I and III	2022*	0.01	14
Total male and female	15 to 24 years	Origin country: Europe (excl. NL)	C01B Antiarrhythmics, class I and III	2022*	0.00	6
Total male and female	15 to 24 years	Origin country: outside Europe	C01B Antiarrhythmics, class I and III	2022*	0.01	18
Total male and female	15 to 24 years	Origin country: Morocco	C01B Antiarrhythmics, class I and III	2022*	0.01	32
Total male and female	15 to 24 years	Origin country: Turkey	C01B Antiarrhythmics, class I and III	2022*	0.01	30
Total male and female	15 to 24 years	Origin country: Suriname	C01B Antiarrhythmics, class I and III	2022*	0.00	0
Total male and female	15 to 24 years	Origin country: Dutch Caribbean	C01B Antiarrhythmics, class I and III	2022*	0.01	35
Total male and female	15 to 24 years	Origin country: Indonesia	C01B Antiarrhythmics, class I and III	2022*	0.01	5
Total male and female	15 to 24 years	Origin country: Outside Europe (exc. 5..	C01B Antiarrhythmics, class I and III	2022*	0.01	13
Total male and female	25 to 34 years	Total	C01B Antiarrhythmics, class I and III	2022*	0.02	30
Total male and female	25 to 34 years	Origin: born in the Netherlands	C01B Antiarrhythmics, class I and III	2022*	0.02	36
Total male and female	25 to 34 years	Origin: born in NL, parents in NL	C01B Antiarrhythmics, class I and III	2022*	0.02	37
Total male and female	25 to 34 years	Origin: born in NL, parent(s) abroad	C01B Antiarrhythmics, class I and III	2022*	0.02	33
Total male and female	25 to 34 years	Origin: born in NL, 1 parent born in NL	C01B Antiarrhythmics, class I and III	2022*	0.02	43
Total male and female	25 to 34 years	Origin: born in NL,2 parents born abroad	C01B Antiarrhythmics, class I and III	2022*	0.02	25
Total male and female	25 to 34 years	Origin: born abroad	C01B Antiarrhythmics, class I and III	2022*	0.01	10
Total male and female	25 to 34 years	Origin country: The Netherlands	C01B Antiarrhythmics, class I and III	2022*	0.02	37
Total male and female	25 to 34 years	Origin country: abroad	C01B Antiarrhythmics, class I and III	2022*	0.01	18
Total male and female	25 to 34 years	Origin country: Europe (excl. NL)	C01B Antiarrhythmics, class I and III	2022*	0.01	22
Total male and female	25 to 34 years	Origin country: outside Europe	C01B Antiarrhythmics, class I and III	2022*	0.01	16
Total male and female	25 to 34 years	Origin country: Morocco	C01B Antiarrhythmics, class I and III	2022*	0.01	11
Total male and female	25 to 34 years	Origin country: Turkey	C01B Antiarrhythmics, class I and III	2022*	0.02	22
Total male and female	25 to 34 years	Origin country: Suriname	C01B Antiarrhythmics, class I and III	2022*	0.02	39
Total male and female	25 to 34 years	Origin country: Dutch Caribbean	C01B Antiarrhythmics, class I and III	2022*	0.01	5
Total male and female	25 to 34 years	Origin country: Indonesia	C01B Antiarrhythmics, class I and III	2022*	0.03	75
Total male and female	25 to 34 years	Origin country: Outside Europe (exc. 5..	C01B Antiarrhythmics, class I and III	2022*	0.01	8
Total male and female	35 to 44 years	Total	C01B Antiarrhythmics, class I and III	2022*	0.05	91
Total male and female	35 to 44 years	Origin: born in the Netherlands	C01B Antiarrhythmics, class I and III	2022*	0.06	107
Total male and female	35 to 44 years	Origin: born in NL, parents in NL	C01B Antiarrhythmics, class I and III	2022*	0.06	114
Total male and female	35 to 44 years	Origin: born in NL, parent(s) abroad	C01B Antiarrhythmics, class I and III	2022*	0.04	68
Total male and female	35 to 44 years	Origin: born in NL, 1 parent born in NL	C01B Antiarrhythmics, class I and III	2022*	0.05	75
Total male and female	35 to 44 years	Origin: born in NL,2 parents born abroad	C01B Antiarrhythmics, class I and III	2022*	0.04	62
Total male and female	35 to 44 years	Origin: born abroad	C01B Antiarrhythmics, class I and III	2022*	0.03	44
Total male and female	35 to 44 years	Origin country: The Netherlands	C01B Antiarrhythmics, class I and III	2022*	0.06	114
Total male and female	35 to 44 years	Origin country: abroad	C01B Antiarrhythmics, class I and III	2022*	0.03	51
Total male and female	35 to 44 years	Origin country: Europe (excl. NL)	C01B Antiarrhythmics, class I and III	2022*	0.03	45
Total male and female	35 to 44 years	Origin country: outside Europe	C01B Antiarrhythmics, class I and III	2022*	0.03	54
Total male and female	35 to 44 years	Origin country: Morocco	C01B Antiarrhythmics, class I and III	2022*	0.04	66
Total male and female	35 to 44 years	Origin country: Turkey	C01B Antiarrhythmics, class I and III	2022*	0.04	71
Total male and female	35 to 44 years	Origin country: Suriname	C01B Antiarrhythmics, class I and III	2022*	0.03	50
Total male and female	35 to 44 years	Origin country: Dutch Caribbean	C01B Antiarrhythmics, class I and III	2022*	0.06	111
Total male and female	35 to 44 years	Origin country: Indonesia	C01B Antiarrhythmics, class I and III	2022*	0.04	78
Total male and female	35 to 44 years	Origin country: Outside Europe (exc. 5..	C01B Antiarrhythmics, class I and III	2022*	0.02	36
Total male and female	45 to 54 years	Total	C01B Antiarrhythmics, class I and III	2022*	0.17	325
Total male and female	45 to 54 years	Origin: born in the Netherlands	C01B Antiarrhythmics, class I and III	2022*	0.19	361
Total male and female	45 to 54 years	Origin: born in NL, parents in NL	C01B Antiarrhythmics, class I and III	2022*	0.19	365
Total male and female	45 to 54 years	Origin: born in NL, parent(s) abroad	C01B Antiarrhythmics, class I and III	2022*	0.17	320
Total male and female	45 to 54 years	Origin: born in NL, 1 parent born in NL	C01B Antiarrhythmics, class I and III	2022*	0.19	357
Total male and female	45 to 54 years	Origin: born in NL,2 parents born abroad	C01B Antiarrhythmics, class I and III	2022*	0.11	237
Total male and female	45 to 54 years	Origin: born abroad	C01B Antiarrhythmics, class I and III	2022*	0.10	190
Total male and female	45 to 54 years	Origin country: The Netherlands	C01B Antiarrhythmics, class I and III	2022*	0.19	365
Total male and female	45 to 54 years	Origin country: abroad	C01B Antiarrhythmics, class I and III	2022*	0.11	221
Total male and female	45 to 54 years	Origin country: Europe (excl. NL)	C01B Antiarrhythmics, class I and III	2022*	0.13	240
Total male and female	45 to 54 years	Origin country: outside Europe	C01B Antiarrhythmics, class I and III	2022*	0.11	212
Total male and female	45 to 54 years	Origin country: Morocco	C01B Antiarrhythmics, class I and III	2022*	0.11	202
Total male and female	45 to 54 years	Origin country: Turkey	C01B Antiarrhythmics, class I and III	2022*	0.14	274
Total male and female	45 to 54 years	Origin country: Suriname	C01B Antiarrhythmics, class I and III	2022*	0.07	154
Total male and female	45 to 54 years	Origin country: Dutch Caribbean	C01B Antiarrhythmics, class I and III	2022*	0.12	280
Source: CBS.

Explanation of symbols

Dataset is not available.

This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.

Data are broken down by medicine group, origin, age and sex.

Data available from 2020.

Status of the figures:
Figures for 2022 are provisional.

Changes as of December 20, 2023:
- Provisional figures for 2022 have been added, provisional figures of 2020 and 2021 have been made definite.
- Textual change: the description of drug group Y (Not filled in) has been replaced by Z (Not applicable). However, the underlying resources have remained the same. This category is assigned to products that do not have an ATC code according to the WHO ATC classification system.

When will new figures be published?
New figures will be published in the last quarter of 2024.

Description topics

Persons with medicines, relative: Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.
Defined daily doses (DDD), relative: Defined Daily Dose (DDD) is de door de WHO vastgestelde gemiddelde dagelijkse dosis van een geneesmiddel, wanneer het geneesmiddel wordt ingezet voor de hoofdindicatie, bij een onderhoudsbehandeling voor volwassenen. Deze definitie maakt het mogelijk om het gebruik van verschillende toedieningsvormen en verschillende middelen met elkaar te vergelijken.

WHO: World Health Organisation, Wereldgezondheidsorganisatie